Preparation and Modification of Collagen/Sodium Alginate-Based Biomedical Materials and Their Characteristics

Leilei Sun, Yanyan Shen, Mingbo Li, Qiuting Wang, Ruimin Li, Shunmin GongPolymers 2024 · DOI

TL;DR

This paper presents a novel, eco-friendly approach to creating collagen/sodium alginate (C/SA) composite sponges for biomedical applications, particularly as hemostatic dressings. By employing different cross-linking methods, the researchers successfully enhanced the material's mechanical strength and absorption capabilities, demonstrating its potential for effective wound management.

What Problem Does This Paper Address?

Traditional collagen-based biomaterials, while possessing excellent biocompatibility, often suffer from poor mechanical strength and limited stability, hindering their widespread use in demanding biomedical applications like hemostatic dressings. Furthermore, concerns surrounding the sourcing of animal-derived collagen (e.g., risk of zoonotic diseases) have spurred interest in alternative sources, such as marine collagen from tilapia. Sodium alginate (SA), a readily available biopolymer, offers complementary properties like high hydrophilicity and the ability to form hydrogels. However, effectively combining collagen and SA into a stable, high-performing composite material that addresses the limitations of individual components requires careful modification and cross-linking. This study aims to develop and characterize C/SA composite sponges with improved hemostatic properties by exploring different cross-linking strategies.

Methods

The researchers prepared C/SA composite sponges using a vacuum freeze-drying method. They investigated two primary cross-linking strategies:

  • EDC/NHS Cross-linking: This is a common chemical cross-linking method that activates carboxyl groups on collagen (aspartic and glutamic acid) to form amide bonds with amine groups (lysine and hydroxylysine).
  • Oxidized Sodium Alginate (OSA) Cross-linking: Sodium alginate was oxidized using sodium periodate to introduce aldehyde groups. These aldehyde groups then react with the amine groups on collagen to form a cross-linked network.

The prepared sponges were then characterized for:

  • Microstructure: Using scanning electron microscopy (SEM) to visualize surface and internal pore structures.
  • Chemical Structure: Employing Fourier Transform Infrared Spectroscopy (FTIR) to confirm cross-linking and chemical modifications.
  • Mechanical Properties: Measuring tensile strength and elongation at break using a texture analyzer.
  • Hygroscopicity: Assessing the material's ability to absorb water, mimicking wound exudate.
  • Porosity: Determining the pore volume using a liquid replacement method.
  • Hemostatic Activity: Evaluating blood clotting time (static and dynamic assays) and calculating the blood clotting index (BCI).
  • Blood Compatibility: Assessing hemolysis ratio (HR) to determine potential red blood cell damage.

Datasets

Not discussed in the paper. The study utilized fresh whole blood from male Wistar rats for in vitro assays.

Key Insights and Ideas

  • Synergistic Properties: Combining collagen and sodium alginate creates a composite material with enhanced properties beyond those of the individual components, particularly for hemostatic applications.
  • Cross-linking is Key: Chemical cross-linking significantly improves the mechanical stability and hygroscopicity of C/SA sponges, making them more robust and effective in absorbing wound exudate.
  • OSA as a "Green" Cross-linker: Oxidized sodium alginate offers a promising, potentially more biocompatible alternative to traditional chemical cross-linkers like EDC/NHS, while still achieving significant improvements.
  • High Porosity is Crucial: All sponge formulations exhibited very high porosity (>95%), which is essential for efficient absorption of wound exudate and blood, facilitating rapid hemostasis.
  • Excellent Hemostatic Potential: The C/SA sponges, especially the cross-linked versions, demonstrated a significant reduction in blood clotting time and a favorable blood clotting index, outperforming even a commercial product in some aspects.
  • Favorable Blood Compatibility: The hemolysis assay indicated that the C/SA sponges are nearly non-hemolytic, suggesting good hemocompatibility for biomedical use.

Key Results

  • Porosity: All C/SA sponges (non-cross-linked, EDC/NHS, and OSA cross-linked) exhibited high porosity, exceeding 95% (ranging from 96.78% to 96.97%).
  • Mechanical Strength: The EDC/NHS cross-linked C/SA sponge showed the highest tensile strength (310.22 ± 61.96 KPa), significantly higher than the non-cross-linked C/SA (50.92 ± 1.84 KPa) and C/OSA (54.44 ± 2.95 KPa) sponges.
  • Hygroscopicity: Sponges cross-linked with EDC/NHS and OSA showed the highest hygroscopicity, indicating improved absorption capabilities.
  • Blood Coagulation Time: All fabricated C/SA sponges significantly shortened blood coagulation time compared to the control, with non-cross-linked C/SA showing the fastest clotting time (101 ± 9 s).
  • Blood Clotting Index (BCI): EDC/NHS cross-linked and C/OSA sponges demonstrated better coagulation activity, with significantly lower BCI values, especially at the early stages of clotting, compared to non-cross-linked C/SA.
  • Hemolysis Ratio (HR): All C/SA sponges showed low hemolysis ratios (ranging from 1.53% to 4.92%), indicating good blood compatibility and acceptance within acceptable limits.

Limitations and Future Work

  • Limitations:
    • The study primarily focused on in vitro hemostatic activity. In vivo studies would be necessary to fully assess the performance of these materials in a biological environment.
  • While OSA is presented as a "green" alternative, a detailed comparison of its long-term biocompatibility and degradation profile versus EDC/NHS would be beneficial.
  • The paper mentions that the non-cross-linked C/SA material became loose after prolonged immersion, suggesting potential stability issues that might require further investigation for specific applications.
  • Future Work:
    • Further investigation into in vivo hemostatic performance and wound healing capabilities.
  • Exploration of other marine-derived collagen sources or modifications to further optimize properties.
  • Detailed studies on the degradation kinetics and cellular interactions of the C/SA sponges.
  • Scaling up the production process for potential clinical translation.

Summary updated

Abstract

(1) Background: Collagen and sodium alginate are commonly used in the field of biomedical materials due to their excellent biocompatibility. This study focuses on the preparation, modification, and characterization of collagen/sodium alginate (C/SA)-based biomedical materials. (2) Methods: The characteristics, including surface chemistry, mechanical properties, hygroscopicity, and porosity, were analyzed. The hemostatic activity in vitro was measured using a blood clotting assay and dynamic blood clotting assay. (3) Results: The results from microstructure and porosity measurement revealed that all of the sponges exhibited a porosity of more than 95 percent. The sponge cross-linked with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS) showed better tensile strength and lower elongation at break. The sponges cross-linked with EDC/NHS and oxidized sodium alginate (OSA) exhibited the highest hygroscopicity in comparison with the uncross-linked sponge. (4) Conclusions: Our study demonstrated that the C/SA-based material we prepared exhibited a high level of porosity, enabling efficient absorption of tissue exudate and blood. Additionally, the materials revealed excellent hemocompatibility, making them suitable for use as a hemostatic dressing in the field of biomedical materials.
BibTeX
@inproceedings{sun2024preparation,
  author = {Leilei Sun and Yanyan Shen and Mingbo Li and Qiuting Wang and Ruimin Li and Shunmin Gong},
  title = {{Preparation and Modification of Collagen/Sodium Alginate-Based Biomedical Materials and Their Characteristics}},
  booktitle = {Polymers},
  year = {2024},
  doi = {10.3390/polym16020171},
}
Figure